In a very modern review, we claimed the identification along with the characterization of a completely new atypical opioid receptor with exceptional adverse regulatory properties in direction of opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is https://edgartyudh.bloggip.com/29462752/conolidine-an-overview